The Anticoagulation certificate program provides pharmacists with the basic knowledge and skills necessary to care for patients taking anticoagulation therapies. With expanded use of anticoagulant agents, the number of patients receiving these drugs has increased dramatically. Safe and effective anticoagulation must include a number of key components to avoid complications. These include careful patient assessment, an understanding of the clotting cascade and mechanisms of action of anticoagulant therapies, a detailed focus on factors which influence therapy and knowledge of current guidelines.
This certificate training program's 22 hours of continuing education (14 hours of home study and 8 hours of live training) is a comprehensive program.
Certificate Course Home-Study Module (14 hours)
The didactic home study will consist of:
- Reading selected monographs relating to the 2012 ACCP Chest Evidence-Based Guidelines,
- View the 2 videos
- Completing a study guide with assessment questions, and
- Complete an on-line assessment test. Note: A score of at least 70% or better is needed in order to qualify as passed.
Upon registration, a link to the home study content will be emailed to the email address indicated on registration. The self-study exam must be completed prior to the live session. As you check in to the live session we will confirm your completion of the study guide. Pharmacists will receive CPE credits of a total of 14 hours or 1.4 CEUs for the home study portion of this program.
- Differentiate the pharmacology and pharmacokinetics of UFH, LMWH, warfarin, direct thrombin inhibitors, and factor XA inhibitors
- Define the current recommendations for indication-specific intensity and duration of anticoagulation treatment
- Recognize strategies used to manage hemorrhagic complications and HIT associated with anticoagulant therapy
- Identify appropriate methods to manage antithrombotic therapy during the perioperative time period
Certificate Course Agenda (8 Hour Live Training)
The live program involves 8 hours (0.80 CEUs) of both lecture and simulation training. Participants will focus on the pathophysiology of thrombosis, receive an overview of ACCP Guidelines, discuss indications for anticoagulation therapy, warfarin dosing and monitoring, management of the over-anticoagulated patient and patients requiring procedure management, patient education, and patient interviewing and assessment. Participants will also learn about point-of care monitoring devices, and practice assessing patients through the use of patient cases. At the conclusion of the live program an on-line, final exam must be completed with a score of at least 70% correct responses in order to receive a certificate of completion. Pharmacists will receive a total of 8 hours or 0.8 CEUs for completion of this component.
- Review pathophysiology of thrombosis
- Describe the difference in mechanism of action between the new and old antithrombotic therapies
- Describe the indications for anticoagulation therapy
- Review current treatment guidelines
- Evaluate the initiation and dosing of warfarin
- Determine factors influencing dosing of warfarin and the appropriate management of out-of-range INRs
- Develop assessment tools which account for variables impacting warfarin intensity and dosing
- Compare and contrast available point of care devices for anticoagulation therapies and demonstrate correct patient care procedures for testing
- Evaluate ‘bridging” therapies for anticoagulation management
- Practice assessing patients on anticoagulation therapies through the use of patient cases
Anticoagulation Certificate: In order to receive your certificate of completion, you must successfully complete both parts of the Anticoagulation Certificate Program.
Pathophysiology and Antithrombotic Therapies
- How new (and old) antithrombotic therapies work
Indications for Anticoagulation and Guideline Review
- Atrial fibrillation
- Heart valves
Initiation and dosing of warfarin
- Starting dose
- When to monitor
- Dose adjustment
Factors influencing dosing of warfarin
- Drug interactions
- Food interactions
- Special populations (elderly, renal, liver, etc)
Managing out-of-range INRs
Patient education and patient interview
POC device for monitoring
New anticoagulants: dabigatran, rivaroxaban, apixaban
- Studies leading to approval
- Approved indication
- Procedural issues
- Elderly initiation
- Elevated INR
- New AC agent
The Arizona Pharmacy Association is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. The application-based self-study learning portion and live training seminar of the Anticoagulation Certificate Program is approved for 22 hours (2.2 CEUs) of continuing pharmacy education credit (UAN: 0100-9999-15-086-B01-P).